Current and New Therapeutic Strategies for Relapsed and Refractory Multiple Myeloma: An Update

Overview of attention for article published in Drugs, November 2017

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#25 of 3,511)
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

news: 21 news outlets
policy: 2 policy sources
twitter: 1 X user

patent: 4 patents
facebook: 1 Facebook page

Citations

dimensions_citation: 109 Dimensions

Readers on

mendeley: 136 Mendeley

Summary News Policy documents X Patents Facebook Dimensions citations

So far, Altmetric has seen 4 patents that reference this research output.

Methods for treating multiple myeloma and the use of companion biomarkers for 4-(4-(4-(((2…

Grant US-11726080-B2

United States of America

METHODS OF PROGNOSING, DETERMINING TREATMENT COURSE AND TREATING MULTIPLE MYELOMA

Application WO-2022097142-A2

World Intellectual Property Organisation (WIPO)

METHODS OF TREATING MULTIPLE MYELOMA WITH A TRIPLET THERAPY OF CARFILZOMIB, DEXAMETHASONE…

Application WO-2021222524-A1

World Intellectual Property Organisation (WIPO)

Methods for treating multiple myeloma and the use of companion biomarkers for 4-(4-(4-(((2…

Grant US-10969381-B2

United States of America

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.